HCAT — HEALTH CATALYST INC

Ownership history in nVerses Capital, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which nVerses Capital, LLC reported a position in HEALTH CATALYST INC (HCAT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2025 Q4)
Avg. % of fund
0.03%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 10,341 +3,041 +41.7% 0.06% $25K $2.39
2025 Q3 UNCHANGED 7,300 — 0% 0.03% $59K $2.85
2025 Q2 UNCHANGED 7,300 — 0% 0.03% $59K $3.77
2025 Q1 UNCHANGED 7,300 — 0% 0.03% $59K $4.53
2024 Q4 UNCHANGED 7,300 — 0% 0.03% $59K $7.07
2024 Q3 INITIATED 7,300 — — 0.03% $59K $8.14
% of Fund (quarterly)    HCAT price (monthly, adj. close)

Other funds also holding HCAT

As of 2025 Q4 — sorted by position size

Whetstone Capital Advisors, LLC 3Y 7Y 2.8% First Light Asset Management, LLC 3Y 7Y 2.36% Nepsis Inc. 3Y 7Y 1.41% Palogic Value Management, L.P. 3Y 1.27% HighMark Wealth Management LLC 3Y 0.72% MARTIN & CO INC /TN/ 3Y 7Y 0.21% PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.07% CVS HEALTH Corp 3Y 0.06% Williams & Novak, LLC 0.05% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.05%
← Back to nVerses Capital, LLC Holdings